Clinical and Biomarker Characteristic of Lymphoma Patients in Hasan Sadikin Lymphoma Registry.

Amaylia OehadianAndini KartikasariLusi MersianaStephanie Victoria GunadiGusti FunganiPutri VidyaniatiDimmy PrasetyaIndra WijayaPandji Irani FianzaTrinugroho Heri FadjariNanny Natalia M Soetedjo

Published in: Journal of blood medicine (2024)

Hodgkin lymphoma and DLBCL had similar clinical and biomarker characteristics. There were slight differences between the three biomarkers SII, ALI, and PNI based on the disease stage. Almost all patients still survived at 2-year follow-up.

Keyphrases

end stage renal disease
ejection fraction
hodgkin lymphoma
newly diagnosed
chronic kidney disease
diffuse large b cell lymphoma
prognostic factors
patient reported